logo

For the Inventor, By the Inventor

Lahntal, Germany

Werner Stuber

USPTO Granted Patents = 24

Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 188(Granted Patents)


Company Filing History:

goldMedal20 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
silverMedal2 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
bronzeMedal1 out of 2 
 
Behringwerke Aktiengellschaft
 patents
4. 1 out of 149 
 
Dade Behring Marburg Gmbh
 patents

Years Active: 1987-2000

Loading Chart...
24 patents (USPTO):Explore Patents
1. 6143493 - HCMV-specific peptides, agents therefor and the use thereof (2000-11-07),
2. 5981697 - Synthetic peptides, antibodies against them and their use (1999-11-09),
3. 5859185 - HCMV-specific peptides, agents therefor and the use thereof (1999-01-12),
4. 5744298 - DNA sequences which encode immunoreactive HCMV-specific peptides (1998-04-28),
5. 5712370 - Erythropoietin (EPO) peptides and antibodies directed against these (1998-01-27),
6. 5607858 - Peptide amides, processes for the preparation thereof and agents (1997-03-04),
7. 5599678 - Antibodies which react with fibrinogen fragments E1, E2 and E3 and (1997-02-04),
8. 5556941 - Glycopeptide derivatives, a process for their preparation and (1996-09-17),
9. 5478810 - Peptide amides, processes for the preparation thereof and agents (1995-12-26),
10. 5457114 - Amidinophenylalanine derivatives, a process for the preparation thereof, (1995-10-10),
11. 5334506 - Chromogenic method of detecting endoproteases (1994-08-02),
12. 5254672 - Synthetic peptides which contain sequences from factor VIIa, and the use (1993-10-19),
13. 5204240 - Method and a kit containing means for the kinetic determination of (1993-04-20),
14. 5202416 - Protease absorbent for isolating and purifying proteases, a process for (1993-04-13),
15. 5124478 - Acid-labile anchor groups for the synthesis of peptide amides by a (1992-06-23),

Title: Innovator Spotlight: Werner Stuber

Introduction

Werner Stuber, a prominent inventor based in Lahntal, Germany, has made significant contributions to the field of immunology through his innovative inventions. With a total of 24 patents to his name, Stuber's work predominantly focuses on the development of peptides and agents that enhance the determination of human antibodies and antigens.

Latest Patents

Stuber's latest inventions include a patent for "HCMV-specific peptides, agents therefor and the use thereof," which pertains to peptides designed for the immunochemical determination of human cytomegalovirus (HCMV)-specific antibodies and antigens. This invention offers a novel approach to identify and quantify HCMV-related biomolecules effectively.

Another of his notable patents is titled "Synthetic peptides, antibodies against them and their use." This invention involves the generation of antibodies that preferentially bind to specific fibrinogen fragments E1, E2, and E3, while demonstrating minimal cross-reactivity with fibrin monomer and fibrinogen. It emphasizes synthetic peptides that are synthesized chemically or through genetic manipulations, which also may include additional amino acid sequences.

Career Highlights

Throughout his career, Werner Stuber has worked with prestigious companies, including Behringwerke Aktiengesellschaft and Hoechst Aktiengesellschaft. His experience in these organizations has greatly contributed to his expertise in the field of peptide technology and immunochemistry.

Collaborations

Stuber's innovative journey has also seen him collaborate with notable coworkers, including Leszek Wieczorek and Robert Ziegelmaier. These collaborations have undoubtedly supported the advancement of his research and the successful realization of his inventions.

Conclusion

Werner Stuber's contributions to the field of immunology through his patented inventions exemplify the spirit of innovation and progress. His ongoing work continues to pave the way for new methods of immunochemical determination, showcasing the potential of peptide technology in addressing public health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…